Consent management is one of the most pressing and overlooked challenges in market access today. As privacy regulations expand and oncology programs grow more complex, fragmented consent processes across hubs, SPs, field teams, and channel partners are creating compliance exposure, slowing patient onboarding, and putting programs at risk.
This session explores how leading oncology, specialty and rare brands are replacing manual, siloed consent workflows with a centralized approach that reduces risk, accelerates access, and supports audit-ready reporting across the full therapy journey.
Attend this webinar to:
- Navigate the evolving consent compliance landscape, including HIPAA, GDPR, CCPA, and emerging state laws, and understand what they mean for your oncology and rare disease programs.
- Identify where consent gaps create access barriers and increase compliance exposure across hubs, SPs, FRMs, and copay programs.
- Apply a centralized consent clearinghouse framework that delivers real-time visibility, audit-ready reporting, and seamless integration across your existing platforms.
Who should attend: Commercial and market access leaders, patient services directors, hub operations teams, and compliance stakeholders in biopharma.
